肌内注射四硫代硫酸钠作为急性氰化物中毒解毒剂:临床相关猪模型研究
本研究在麻醉猪模型中经静脉输注氰化钾(0.17 mg/kg/min)至呼吸暂停6分钟后终止输注,分别肌内注射四硫代硫酸钠(约18 mg/kg)或生理盐水。四硫代硫酸钠组生存率为100%,对照组为17%(p=0.0043);治疗组全部恢复自主呼吸,平均时间为给药后10.85分钟,对照组除1例外均持续呼吸暂停至实验结束。治疗组血乳酸自给药后30分钟起改善(p≤0.002),对照组平均死亡时间为63.3±23.2分钟。未观察到肌内注射四硫代硫酸钠的全身或局部不良反应。
要点
- 在严重氰化物中毒猪模型中,肌内注射四硫代硫酸钠(约18 mg/kg)组生存率为100%,生理盐水对照组为17%(p=0.0043)。
- 四硫代硫酸钠组全部动物恢复自主呼吸,平均时间为给药后10.85分钟;对照组除1例外持续呼吸暂停至实验结束。
- 四硫代硫酸钠组血乳酸自给药后30分钟起较对照组改善(p≤0.002)。
- 对照组平均死亡时间为63.3±23.2分钟。
- 未观察到肌内注射四硫代硫酸钠的全身或局部不良反应。
适用人群与场景
- 麻醉猪,经静脉输注氰化钾(0.17 mg/kg/min)至呼吸暂停6分钟(无呼吸持续20秒)后终止输注并给予干预。
处置流程与药物剂量
- 在呼吸暂停6分钟(无呼吸持续20秒)后终止氰化钾输注,肌内注射四硫代硫酸钠约18 mg/kg或生理盐水对照。
- 治疗后持续监测临床参数和实验室指标至死亡或实验终止(治疗后90分钟)。
研究设计与关键结果
- 研究类型:临床相关大型动物(猪)模型研究;样本量未报告;人群:麻醉猪;干预:肌内注射四硫代硫酸钠(约18 mg/kg);对照:生理盐水;主要终点:生存率,四硫代硫酸钠组100% vs 对照组17%(p=0.0043)。
- 四硫代硫酸钠组全部动物恢复自主呼吸,平均时间为给药后10.85分钟;对照组除1例外均持续呼吸暂停至实验结束。
- 四硫代硫酸钠组血乳酸自给药后30分钟起较对照组改善(p≤0.002)。
- 对照组平均死亡时间为63.3±23.2分钟。
- 未观察到肌内注射四硫代硫酸钠的全身或局部不良反应。
证据类型、等级与局限
- 证据类型:动物实验(猪模型);证据等级未报告;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,肌内注射四硫代硫酸钠在大型猪严重氰化物中毒模型中显著改善生存率和临床结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Cyanide is a metabolic poison used in multiple industries and is a high threat chemical agent. Current antidotes require intravenous administration, limiting their usefulness in a mass casualty scenario. Sodium tetrathionate reacts directly with cyanide yielding thiosulfate and the non-toxic compound thiocyanate. Thiosulfate, in turn, neutralizes a second molecule of cyanide, thus, per mole, sodium tetrathionate neutralizes two moles of cyanide. Historical studies examined its efficacy as a cyanide antidote, but it has not been evaluated in a clinically relevant, large animal model, nor has it previously been administered by intramuscular injection.Objective: The objective of this study is to evaluate the efficacy of intramuscular sodium tetrathionate on survival and clinical outcomes in a large, swine model of severe cyanide toxicity.Methods: Anesthetized swine were instrumented for continuous monitoring of hemodynamics, then acclimated and breathing spontaneously prior to potassium cyanide infusion (0.17 mg/kg/min). At 6-min post-apnea (no breaths for 20 s), the cyanide infusion was terminated, and animals were treated with sodium tetrathionate (∼18 mg/kg) or normal saline control. Clinical parameters and laboratory values were evaluated at various time points until death or termination of the experiment (90 min post-treatment).Results: Laboratory values, vital signs, and time to apnea were similar in both groups at baseline and treatment. Survival in the sodium tetrathionate treated group was 100% and 17% in controls (p = 0.0043). All animals treated with sodium tetrathionate returned to breathing at a mean time of 10.85 min after antidote, and all but one control remained apneic through end of the experiment. Animals treated with tetrathionate showed improvement in blood lactate (p ≤ 0.002) starting at 30 min post-treatment. The average time to death in the control group is 63.3 ± 23.2 min. No systemic or localized adverse effects of intramuscular administration of sodium tetrathionate were observed.Conclusion: Sodium tetrathionate significantly improves survival and clinical outcomes in a large, swine model of acute cyanide poisoning.
参考来源
- Hendry-Hofer TB, Witeof AE, Ng PC, et al. Intramuscular sodium tetrathionate as an antidote in a clinically relevant swine model of acute cyanide toxicity. Clin Toxicol (Phila). 2019. PMID: 31008657. doi:10.1080/15563650.2019.1602272
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。